April 2018

#mamsummit Caye: Why she isn't afraid on her career. Snyder: Impt connection w/people where creative dir's are successful.

9:54am April 26th 2018 via Hootsuite

Q: Idea of humanity as a creative dir? #mamsummit Caye: On a pendulum swing of rebellion; a bit of fear. Maker culture; Etsy; farmers mkts

9:53am April 26th 2018 via Hootsuite

#mamsummit Snyder: Understanding behavior; genuine, authentic, not contrived. Messages received and welcomed, a person-to-person level

9:50am April 26th 2018 via Hootsuite

#mamsummit Caye: A human element: turn 'creepy into humanity'? Nature of creativity, how we look at our work, is shifting. What matters?

9:49am April 26th 2018 via Hootsuite

Q: Place for creative dir in a big-data world? #mamsummit O'Brien: AI, frontiers of humanness. How we work will change - need to prepare (!)

9:48am April 26th 2018 via Hootsuite

#mamsummit Snyder: Akseizer Design Group (ADC) does interior design and work for real estate clients (mainly).

9:46am April 26th 2018 via Hootsuite

Creative dir round-table #mamsummit: Tina Caye @Tina_Caye Mike O'Brien @redtablepress Sarah Kate Snyder @SarahKateSnyder

9:42am April 26th 2018 via Hootsuite

Q: Use of SMS? #mamsummit Weiswasser: SMS, in-app messaging has a ton of potential.

9:37am April 26th 2018 via Hootsuite

Q: AI and marketing? #mamsummit Morgan: @BoozAllen 'we use it everyday, something for you to think about'

9:33am April 26th 2018 via Hootsuite

Q: SEO? A: 'Always changing, got to keep up on it.' Q: Twitter? #mamsummit Morgan: @BoozAllen shoutout to @KirkDBorne influence on IT space

9:33am April 26th 2018 via Hootsuite

Q: VR? #mamsummit Weiswasser: Huge implciation for @Homesnap for RE huge potential. Rinehart: For verticals, great, B-C 'too early'

9:31am April 26th 2018 via Hootsuite

Q: Is FB dead? #mamsummit Weiswasser: "I feel people are fatigued, bored, and unenchanted with it. Yes, it's dead."

9:30am April 26th 2018 via Hootsuite

#mamsummit Panelists: Paul Sherman (Potomac Techwire), Kerry Morgan (BoozAllen), Jff Rinehart (FrameBridge), Gayle Weiswasser (HomeSnap)

9:28am April 26th 2018 via Hootsuite

Today I'm at the #mamsummit Mid-Atlantic Marketing Summit CMO Roundtable: attendees regarding 'The Future of Marketing'.

9:28am April 26th 2018 via Hootsuite

This infographic explains the Art & Science of Networking | Ladders https://t.co/HsvsjZTsaK

8:58pm April 25th 2018 via Hootsuite

For Health or For Fun? At-home genetic testing and the boundaries between patient and consumer | GenomeWeb https://t.co/Nj6XhQqwYh

5:40pm April 25th 2018 via Hootsuite

GenomeTV Live at 4PM ET 4/25/18 "Bench to Bedside to Business: A talk on startups in Science" - NHGRI https://t.co/5qPo1ISNOK

3:24pm April 25th 2018 via Hootsuite

Is Biopharma Investing Too Much In Cancer R&D? | Forbes https://t.co/WN93Bhg33V

8:53pm April 24th 2018 via Hootsuite

OncoDNA Study Highlights Use of Multiple Molecular Tests to Improve Cancer Treatment | GenomeWeb $ https://t.co/Q1Ee5cX1kU

7:55pm April 24th 2018 via Hootsuite

Blood test shows promise for spotting early cancers | Science News https://t.co/FfqZBNAVL9 Another take on GRAIL's #AACR18 early results

6:55pm April 24th 2018 via Hootsuite

Anticipating Clinical Launch, Natera Shares New Data on ctDNA Cancer Monitoring Tech | GenomeWeb $ https://t.co/qGIbIRznJ9

5:25pm April 24th 2018 via Hootsuite

How Many Genes Do Cells Need? Maybe Almost All of Them | Quanta Magazine https://t.co/dKh6OCBJRf

4:40pm April 24th 2018 via Hootsuite

Mapping the basic units of life - about the Human Cell Atlas – The Chan Zuckerberg Initiative https://t.co/xUhobskw7e

4:20pm April 24th 2018 via Hootsuite

Kulkarni: #BHCRForum18 Virtualization; automation and machine learning; innovation occurs at small co's.

11:41am April 24th 2018 via Twitter Web Client

Q: Role of VWR, how will 'work get done' change? #BHCRForum18 Kulkarni: new tech will change; for ex, IoT for lab equipment?

11:40am April 24th 2018 via Twitter Web Client

Q: Commentary on the use of 'failure'? #BHCRForum18 Danos: All part of the process of success. How our brains work.

11:39am April 24th 2018 via Twitter Web Client

Kulkarni: #BHCRForum18 More of a generalist in a larger company. Solomon: smaller co's need someone 'who is scrappy' and is proven

11:35am April 24th 2018 via Twitter Web Client

Q:To what level do you interact w/public? #BHCRForum18 Solomon: A really impt thing GeneDx mgmt does.

11:28am April 24th 2018 via Twitter Web Client

Q:What's the first thing you do in the AM? #BHCRForum18 Solomon: instead of PubMed now over LinkedIn and Twitter. Also automated tools.

11:19am April 24th 2018 via Twitter Web Client

Q: % outward-facing? Kulkarni: about 60% #BHCRForum18 Solomon: fluctuates. CSO's role is often 'a sanity check' for new ideas.

11:13am April 24th 2018 via Twitter Web Client

Danos: #BHCRForum18 Everything from ID to IND; can be done w/a variety of partners, experts.

11:09am April 24th 2018 via Twitter Web Client

Q: What does a CSO do? #BHCRForum18 Solomon: When you get to a certain size, you need a way to track and be acct'ble

11:02am April 24th 2018 via Twitter Web Client

CSOs #BHCRForum18 Solomon: single-best thing was to hire a top CSO, didn't have a traditional one before 'made a world of difference'

11:00am April 24th 2018 via Twitter Web Client

CSOs #BHCRForum18 Kulkarni (Avantor) now is VWR and JT Baker - 13k empl. $6.5B value closed Nov '17 https://t.co/yCaN8QQAM4

10:57am April 24th 2018 via Twitter Web Client

CSOs #BHCRForum18 Danos (RegenX) gene therapy co, started in Philly now in Rockville. AAV-based, 4 active trials incl wet macular degen

10:55am April 24th 2018 via Twitter Web Client

CSOs #BHCRForum18 Jackson (Emergent) intro: Anthrax from DoD and HHS, local success story. Mid-size pharma, see themselves as gov't partner

10:52am April 24th 2018 via Twitter Web Client

Salgaller: #BHCRForum18 They have 60 people in licensing. Cumbersome - no, experts in transactions. Internal ideas only, no...

10:24am April 24th 2018 via Twitter Web Client

Salgaller: #BHCRForum18'NIH as your tech dev and commercialization partner'. He was 20y in industry; lists 5 myths of working w/NIH...

10:23am April 24th 2018 via Twitter Web Client

Powers: #BHCRForum18 Attractive rare disease area; also Model Of Non-Alcoholic Steatohepatitis (NASH); also NSCLC platform

10:21am April 24th 2018 via Twitter Web Client

Powers: #BHCRForum18 And large Takeda collab https://t.co/O6O3SgQi7q (up to $470M)

10:19am April 24th 2018 via Twitter Web Client